Alpl-1 is a target for chimeric antigen receptor therapy in osteosarcoma
Publication date:
2023
Publisher version:
Citación:
Nature Communications, 14(1) (2023); doi:10.1038/s41467-023-39097-x
Patrocinado por:
This body of the European Union receives support from the European Union’s Horizon 2021 research and innovation program. C.P. is supported by a PFIS fellowship from Instituto de Salud Carlos III (ISCIII)(FI21/00161). Figures 3a, 3e, 4a, ad Supplementary Fig. 4a were prepared using BioRender.com
Collections
- Artículos [36261]
- Investigaciones y Documentos OpenAIRE [7903]
- Medicina [934]
Files in this item
Métricas
Compartir
Estadísticas de uso
Metadata
This item is protected with a Creative Commons License